Cresco Labs (FRA:6CQ) Cyclically Adjusted Book per Share: €-5.08 (As of Mar. 2026)


FRA:6CQ Cresco Labs Inc FRA:6CQ
37 GF Score
Price €0.64
GF Value €0.78
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted Book per Share?

Cresco Labs FRA:6CQ +3.86% 37 Cyclically Adjusted Book per Share is €-5.08 as of Mar. 2026. GuruFocus rates FRA:6CQ with a GF Score™ of 37/100 and a GF Value™ of €0.78 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cresco Labs's adjusted book value per share for the three months ended in Mar. 2026 was €0.785. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-5.08 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 20.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cresco Labs was 20.20% per year. The lowest was -42.00% per year. And the median was -5.40% per year.

As of today (2026-07-10), Cresco Labs's current stock price is €0.638. Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €-5.08. Cresco Labs's Cyclically Adjusted PB Ratio of today is .


Cresco Labs  (FRA:6CQ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cresco Labs Cyclically Adjusted Book per Share Related Terms


Cresco Labs Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted Book per Share Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.25 -15.10 -11.91 -8.47 -6.23

Cresco Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.06 -7.13 -7.12 -6.23 -5.08

FRA:6CQ vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


FRA:6CQ
37GF Score
Cresco Labs Inc FRA:6CQ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.785/330.2130*330.2130
=0.785

Current CPI (Mar. 2026) = 330.2130.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201604 -21.743 239.261 -30.008
201607 -21.943 240.628 -30.112
201610 -21.629 241.729 -29.546
201701 -24.743 242.839 -33.646
201704 -23.943 244.524 -32.333
201707 -24.771 244.786 -33.416
201710 -23.914 246.663 -32.014
201801 -24.914 247.867 -33.191
201804 -24.286 250.546 -32.008
201807 -22.343 252.006 -29.277
201810 -0.212 252.885 -0.277
201903 0.953 254.202 1.238
201906 0.911 256.143 1.174
201909 1.207 256.759 1.552
201912 1.280 256.974 1.645
202003 2.745 258.115 3.512
202006 2.550 257.797 3.266
202009 2.397 260.280 3.041
202012 1.741 260.474 2.207
202103 2.117 264.877 2.639
202106 2.738 271.696 3.328
202109 2.080 274.310 2.504
202112 2.300 278.802 2.724
202203 2.251 287.504 2.585
202206 2.530 296.311 2.819
202209 2.648 296.808 2.946
202212 1.965 296.797 2.186
202303 1.879 301.836 2.056
202306 1.711 305.109 1.852
202309 1.405 307.789 1.507
202312 1.365 306.746 1.469
202403 1.353 312.332 1.430
202406 1.250 314.175 1.314
202409 1.184 315.301 1.240
202412 1.301 315.605 1.361
202503 1.212 319.799 1.251
202506 1.084 322.561 1.110
202509 1.021 324.800 1.038
202512 0.809 324.054 0.824
202603 0.785 330.213 0.785

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-5.08 mean?
Cresco Labs (FRA:6CQ) has a Cyclically Adjusted Book per Share of €-5.08 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cresco Labs and its competitors.
Is Cresco Labs' Cyclically Adjusted Book per Share too high?
Cresco Labs' current Cyclically Adjusted Book per Share is €-5.08. Overall, Cresco Labs has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Cresco Labs' Cyclically Adjusted Book per Share of €-5.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cresco Labs and its competitors. Cresco Labs's current Cyclically Adjusted Book per Share is €-5.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (FRA:6CQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.78, compared to a current price of €0.64 — trading 18.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is €-5.08. Cresco Labs' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cresco Labs (FRA:6CQ), the current Cyclically Adjusted Book per Share is €-5.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cresco Labs (FRA:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.64 is trading 18.2% below its estimated GF Value™ of €0.78. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for FRA:6CQ:

  • Cyclically Adjusted Book per Share: €-5.08
  • GF Value™: €0.78 vs. price of €0.64 (18.2% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
37GF Score

Get the complete analysis for FRA:6CQ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.64
Price
€0.78
GF Value